Works by Luo, Cheng-Feng

Results: 9

Atrial Fibrillation Types and Chronic Kidney Disease are Independent Predictors of Atrial Fibrillation Recurrence After Radiofrequency Ablation.

Published in:

Therapeutics & Clinical Risk Management, 2024, v. 20, p. 817, doi. 10.2147/TCRM.S492265

By:

Mo, Pei;
Fan, Cheng;
Chen, Jiayuan;
Wang, Yu;
Xiao, Wenhao;
Peng, Zhiguo;
Lin, Xiao-Zhen;
Luo, Cheng-Feng;
Zhang, Chongyu

Publication type:

Article

Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis.

Published in:

Thrombosis, 2015, p. 1, doi. 10.1155/2016/1031794

By:

Liu, Bei;
Duan, Chong-Yang;
Luo, Cheng-Feng;
Ou, Cai-Wen;
Wu, Zhi-Ye;
Zhang, Jian-Wu;
Ni, Xiao-Bin;
Chen, Ping-Yan;
Chen, Min-Sheng

Publication type:

Article

Puerarin-7- O-glucuronide, a water-soluble puerarin metabolite, prevents angiotensin II-induced cardiomyocyte hypertrophy by reducing oxidative stress.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, v. 390, n. 5, p. 535, doi. 10.1007/s00210-017-1353-8

By:

Hou, Ning;
Cai, Bin;
Ou, Cai-Wen;
Zhang, Zhen-Hui;
Liu, Xia-Wen;
Yuan, Mu;
Zhao, Gan-Jian;
Liu, Shi-Ming;
Xiong, Long-Gen;
Luo, Jian-Dong;
Luo, Cheng-Feng;
Chen, Min-Sheng

Publication type:

Article

Human UDP-Glucuronosyltransferase 2B4 and 2B7 Are Responsible for Naftopidil Glucuronidation in Vitro.

Published in:

Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2017.00984

By:

Liu, Xia-Wen;
Rong, Yi;
Zhang, Xing-Fei;
Huang, Jun-Jun;
Cai, Yi;
Huang, Bi-Yun;
Zhu, Liu;
Wu, Bo;
Hou, Ning;
Luo, Cheng-Feng

Publication type:

Article

Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis.

Published in:

Stem Cells International, 2015, p. 1, doi. 10.1155/2016/1031794

By:

Liu, Bei;
Duan, Chong-Yang;
Luo, Cheng-Feng;
Ou, Cai-Wen;
Wu, Zhi-Ye;
Zhang, Jian-Wu;
Ni, Xiao-Bin;
Chen, Ping-Yan;
Chen, Min-Sheng

Publication type:

Article

UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes.

Published in:

Archives of Toxicology, 2012, v. 86, n. 11, p. 1681, doi. 10.1007/s00204-012-0874-7

By:

Luo, Cheng-Feng;
Cai, Bin;
Hou, Ning;
Yuan, Mu;
Liu, Shi-Ming;
Ji, Hong;
Xiong, Long-Gen;
Xiong, Wei;
Luo, Jian-Dong;
Chen, Min-Sheng

Publication type:

Article

Erratum to: UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes.

Published in:

2012

By:

Luo, Cheng-Feng;
Cai, Bin;
Hou, Ning;
Yuan, Mu;
Liu, Shi-Ming;
Ji, Hong;
Xiong, Long-Gen;
Xiong, Wei;
Luo, Jian-Dong;
Chen, Min-Sheng

Publication type:

Correction Notice

Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1–Nrf2 signalling pathway.

Published in:

Journal of Pharmacy & Pharmacology, 2021, v. 73, n. 12, p. 1715, doi. 10.1093/jpp/rgab097

By:

Hou, Ning;
Li, Li-Rong;
Shi, Yong-Ying;
Yuan, Wen-Chang;
Zhao, Gan-Jian;
Liu, Xia-Wen;
Cai, Shao-Ai;
Huang, Yin;
Zhan, Hao-Xin;
Pan, Wei-Biao;
Luo, Cheng-Feng

Publication type:

Article

Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a chinese obese population aged 40–65: a prospective cross-sectional study.

Published in:

Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01942-0

By:

Zhang, Chong-Yu;
Xu, Ru-Qin;
Wang, Xiao-Qiao;
Sun, Lin-Feng;
Mo, Pei;
Cai, Ren-Jie;
Lin, Xiao-Zhen;
Luo, Cheng-Feng;
Ou, Wen-Chao;
Lu, Lie-Jing;
Zhong, Yun;
Chen, Jia-Yuan

Publication type:

Article